In cholesterol-fed rabbits, alloxan-dlabetes has an antt-atherogenlc effect, which is associated with severe elevation of plasma triglyceride concentrations. To study this effect, we measured llpoprotein sizes and aortic permeability coefficients for chotesteryl ester and for albumin In hypertriglycerldemlc diabetic cholesterol-fed rabbits and In normotriglyceridemlc cholesterol-fed rabbits. With the same high cholesterol concentration in plasma, hypertrlglyceridemlc diabetic rabbits had 70% of plasma cholesterol In very large llpoprotelns (diameter >75 nm), whereas normotrlglycerldemlc rabbits had only about 10% of plasma cholesterol in these giant llpoprotelns. The aortic permeability coefficients for cholesteryl ester In hypertriglycerldemlc diabetic cholesterol-fed rabbits was only 10% to 50% of that In normotriglyceridemlc cholesterol-fed rabbits. Aortic permeability coefficients for albumin did not differ significantly between the hypertrlglyceridemlc and normotriglyceridemlc rabbits. The results suggest that the large size of a major fraction of plasma llpoprotelns in the hypertrlglyceridemlc diabetic cholesterol-fed rabbits Is responsible for the relatively low aortic permeability coefficient for cholesteryl ester from plasma and hence for reduced atherogenesis In these animals.
I t Is generally recognized that humans with diabetes mellitus have more atherosclerosis than do nondiabetic humans. This seems to conflict with the finding that the induction of alloxan-diabetes has an anti-atherogenic effect in cholesterol-fed rabbits. 1 -8 The antj-atherogenic effect is not caused by the alloxan injection, per se, 1 or by the effect of alloxan on tissues other than the pancreas. 5 Treatment of these animals with insulin reverses the anti-atherogenic effect. 0 Altoxan-dlabetic rabbits that are protected against atherosclerosis have a parallel rise in plasma cholesterol, lipid phosphorus, and neutral fat. 3 The major part of this elevated plasma cholesterol is carried in the triglyceride-rtch, large, less-dense lipoproteins. 489 When plasma triglycerides are increased only slightly in the alloxan-diabetic rabbit, no antiatherogenic effect is seen. 10 Duff and Payne 3 suggested that elevated plasma lipid phosphorus stabilizes cholesterol in plasma and thereby prevents deposition of cholesterol in the arterial wall of the alloxan-diabetic rabbit. They also postulated that high levels of plasma neutral fat may play some part. Recently, Brecher et al. 8 have shown that the d<1.019 g/ml lipo-protein fraction from diabetic cholesterol-fed rabbits, in contrast to beta very low density lipoprotein (0-VLDL) from nondiabetic cholesterol-fed rabbits, did not stimulate cholesteryl ester formation in mouse peritoneal macrcphages. They suggested that diabetic lipoproteins do not exhibit the appropriate ligands for recognition by macrophages, which could retard the development of foam cell lesions in diabetic animals.
Since the aortic permeability coefficients (intlmal clearances) for plasma proteins, high density lipoproteins (HDL), low density lipoproteins (LDL), and VLDL decrease with increasing macromolecular diameter in hypercholesterolemic rabbits, 11 and since chylomlcrons do not enter the arterial wall, 12 we present an alternative hypothesis: in the hypertriglyceridemic diabetic cholesterol-fed rabbit, the plasma lipoproteins that contain most plasma cholesterol are so large that they are not able to enter the arterial wall. Thus, the subendothelial cells are exposed to only a small amount of cholesterol, and the development of atherosclerosis is retarded.
In the present study, we measured the sizes of plasma lipoproteins and the aortic permeability coefficients for cholesteryl ester and proteins in hypertriglyceridemic diabetic cholesterol-fed rabbits and in various normotriglyceridemic cholesterol-fed rabbits. Our findings support our hypothesis.
Methods Animals
We used male white rabbits weighing 2.5 to 3.5 kg each of the Danish Country strain from Statens Serum Institute (Copenhagen, Denmark). Perrtobarbital (15 mg/kg body weight) was administered intravenously 1 to 2 minutes before the aJloxan injection. The freshly prepared, 10% solution of alloxan monohydrate (Sigma, St. Louis, MO) in physiological saline was administered via the marginal ear vein during a period of less than 5 seconds at a dose of 200 mg/kg of body weight. To counteract hypoglycemia caused by insulin released from necrotic beta cells in the pancreas, subcutaneous injections of 20 ml of 20% glucose were given to the rabbits just before, 4 hours after, 8 hours after, and 12 hours after the alloxan injection.
A total of 53 rabbits were injected with alloxan. Of these rabbits, 10 developed diabetes (blood glucose >10 mmol/l) and severe hypertriglyceridemia (>25 mmol/l), 6 developed diabetes without hypertriglyceridemia, 17 recovered from the alloxan injection, and the remaining 20 died. Rabbits from these three groups, as well as rabbits that had never been injected with alloxan (nondiabetics), were used for influx studies. Fasting blood glucose and plasma triglyceride were measured with Merck's System Glucose No. 14055 (Darmstadt, Federal Republic of Germany) and Boehringer Mannheim's GPO-PAP (Federal Republic of Germany), respectively.
All rabbits were fed cholesterol before the influx studies. Of the eight hypertriglyceridemic diabetic rabbits used for these studies, two were fed cholesterol 6 weeks before the alloxan Injection and for another 2 weeks thereafter, and the other six were fed cholesterol for 15 weeks after they had been injected with alloxan. All normotriglyceridemic rabbits (diabetics, alloxan-recovered, and nondiabetics) were fed cholesterol for 8 to 9 weeks before the influx study. Each cholesterol-fed rabbit daily received 150 g of standard rabbit pellets (Boserup, Faxe, Denmark) containing 7.5 g of com oil and 0 to 6 g of cholesterol. The amount of cholesterol in the diet was individualized to give the different rabbits similar plasma cholesterol levels on the day of the influx study.
The experimental protocols were in accordance with Danish regulations for experiments with animals.
Lipoproteins
Samples of whole plasma aliquots (250 ^J) from hypertriglyceridemic diabetic cholesterol-fed and normotriglyceridemic (diabetic alloxan-recovered nondiabetlc) cholesterol-fed rabbits were applied to a column of 1% agarose (Bio-Gel A150 m, 100 to 200 mesh; Bio-Rad Laboratories, Richmond, CA). The column was 1.4 cm x 80 cm, and the elution buffer was 5 mM Tris-HCI (pH 7.4), 150 mM NaCI, 0.5 mM EDTA. The flow rate was 10 ml/hr. Fractions of 2.8 ml were collected at 4°C. Total cholesterol (CHOD-PAP, Boehringer Mannheim) and triglyceride (GPO-PAP, Boehringer Mannheim) levels in the different fractions were measured by enzymatic methods.
In hypercholesterolemic hypertriglyceridemic diabetic plasma and hypercholesterolemic rmmxrtrigryceridernic (nondiabetic) plasma, lipoproteins with a diameter larger than 75 nm (Sf >400) were separated by ultracentrifugatjon from lipoproteins with a diameter smaller than 75 nm (Sf <400) according to the nomogram of Dole and Hamlin. 13 The total cholesterol was determined by enzymatic methods.
Plasma from hypertriglyceridemic diabetic cholesterol-fed rabbits and from normotriglyceridemic (alloxan-recovered) cholesterol-fed rabbits was adjusted to a density of 1.006,
• CHOLESTEROL a TRIGLYCERIDE 130 ELUTION VOLUME (ml) Figure 1 . Elution profiles of plasma total cholesterol (•) and plasma trigtyceride (D) from gel filtration on 1% agarose of hypercholesterolemic plasma from a normotriglyceridemic nondiabetic rabbit (upper panel), a normotriglyceridemic diabetic rabbit (second panel), a hypertrigtyceridemic diabetic rabbit (third panel), and the same hypertriglyceridemic diabetic rabbit with a higher plasma triglyceride level (lower panel). V 0 =votd volume (determined by Stephyiococcus aureus), V=VLDL (d< 1.019 g/ml), L=LDL (1.019<d<1.063 g/ml) from a hypercholesterolemic rabbit V t =total volume (determined by 22 Ha), G = blood glucose, C = plasma total cholesterol, T = plasma triglyceride. 1.019, and 1.063 g/ml, respectively and these were centrifuged at 4°C at 1.58x Itf'g-min (average). The total cholesterol in the various fractions was determined as previously described. 14 VLDL was the d<1.006 g/ml, intermediate density lipoprotein (IDL) was the 1.006 g/ml<d<1.019 g/ml, LDL was the 1.019 g/ml<d<1.063 g/ml, and HDL was the d>1.063 g/ml fraction.
Donor and Recipient Animals
From two hypertriglyceridemic diabetic cholesterol-fed rabbits, 15 ml of blood were drawn before 5.0 mCi of 1a, 2a(n)-3 H-cholesterol (Amersham, Denmark Aps, Birkerad, Denmark) in 1.5 ml ethanol, and 10 ml of saline was given to the rabbits by stomach tube 16 to 18 hours before exsanguination. At 2 hours before exsanguination, the previously obtained plasma samples were added to 175 /xCi 4-14 C-cholesterol (Amersham) and this was reinjected into the same animals. By this labeling technique, 3 Hcholesterol is preferentially incorporated into esterified cholesterol, and 14 C-cholesterol is preferentially incorporated into the free cholesterol of the lipoproteins. The values for plasma are the means ±SE. *Sf >400, tSf <400. Average of lipoproteins from two rabbits with plasma trigiyceride and total cholesterol of 141 and 94 mmol • I"'. §From two alloxan-recovered rabbits with plasma trigiyceride and total cholesterol of 2 and 70 mmol • I" 1 .
Plasma proteins (mostly albumin) labeled biosyrrthetjcally with 3 H-leuclne or ^-methionine were obtained from four normal rabbits. 14 In vivo labeled lipoproteins and proteins were filtered through 0.45 /xm and 0.22 /un Millipore filters, respectively, and these were immediately injected intravenously into the eight hypertriglyceridemic diabetic cholesterol-fed rabbits (recipients) at 4 to 6 hours before sacrifice. The animals received 24 ±2 ml Upoprotein preparation with 184±14 (jJZ\ 3 H-cholesteryl ester, 28±4 p€i 3 H-free cholesterol, and 8± 1 fiC\ 1 *C-free cholesterol, and 17± 1 ml plasma protein preparation with 9 ± 0 /iCi 3 H-protein or 7 ± 3 nC\ "S-protein.
In each of the three groups of normotriglyceridemic cholesterol-fed rabbits, the recipient animals were Injected with labeled lipoproteins (13±2 ml with 65±14 jtCi 3 H-cholesteryl ester, 7±2 /iCi 3 H-free cholesterol, and 5 ± 1 /xCi 14 C-free cholesterol) and with labeled plasma proteins (19±1 ml with 9±0 /^Ci 3 H-protein or 7±1 fiCî S-protein). These were prepared as described above from a lipoprotein donor animal from each of the three different groups. The same labeled plasma protein preparations were used both for hypertriglyceridemic and for normotriglyceridemic recipient rabbits. Blood samples for determination of specific activities in plasma were drawn at regular intervals from the time of injection of the labeled preparations until the rabbits were anesthetized by i.v. injections of a 5% pentobarbital solution (50 to 100 mg/kg body weight) and the thoracic aorta was removed. 14
Analytical Procedure
Plasma samples and tissue samples were extracted with chloroform/methanol, 1:1 (vol/vol), lipids and proteins were separated, and radioactivity and mass of free cholesterol, esterified cholesterol, and proteins were determined as previously described. 1415
Calculations
The transcapillary escape rates (the fraction of intravascular mass of a component that disappears from the intravascular space per hour) for plasma proteins, free cholesterol, and esterified cholesterol were determined as being the rate constant when plasma disappearance curves for the labeled components in the time interval from 10 to 60 minutes after the tracer injections were fitted to monoexponential functions. 16 This determination is based on the assumption that the labeled compounds are stable within the plasma compartment, which is valid for labeled albumin and labeled esterified cholesterol. For practical purposes, this is also valid for labeled free cholesterol, since less than 2% of 14 C-free cholesterol was esterified within the first 60 minutes. Volumes of distribution for the labeled compounds in the rabbits were calculated by dividing the injected amounts of labeled material by the concentrations of labeled material in plasma at time zero, obtained by extrapolation. The disappearance from the intravascular pool was calculated by multiplication of the transcapillary escape rate by the pool size; the pool size was calculated as the volume of distribution multiplied by the plasma concentration.
Influx of plasma proteins (mostly albumin), free cholesterol, and cholesteryl ester into the intima-media layer of the proximal aorta was calculated by the "sink" method, in which the amount of radioactivity in the tissue is divided by the area below the plasma specific activity versus the time curve (4 to 6 hours) of the corresponding component. To correct for hydrolysis of labeled esterifled cholesterol and for estertfication of labeled free cholesterol in the arterial tissue, a set of linear equations was used. 14 The aortic permeability coefficients or intJmal clearances for albumin, free cholesterol, and esterified cholesterol were calculated by dividing the influx by the plasma concentration of the corresponding constituent.
Statistics
The results are shown as the means ± standard errors. The differences between hypertriglyceridemic diabetic cholesterol-fed rabbits and the three groups of normotriglyceridernic cholesterol-fed rabbits were tested by Wilcoxon's two-sample rank test (Mann-Whitney test).
Results

Animals and Alloxan Infection
When the animals were fed cholesterol before the alloxan injection, only 4 out of 22 animals became diabetic. Contrarily, when alloxan was injected into normal rabbits, 12 out of 31 became diabetic. During the first week after the alloxan injection, the rabbits lost 100 to 500 g of body weight Thereafter, the rabbits began eating again and at the time of the influx measurements all rabbits were eating well.
Llpoprotelns
The upper panel of Figure 1 shows elutJon profiles of plasma total cholesterol and of plasma trtglyceride from a normotriglyceridemic nondiabetic cholesterol-fed rabbit The second panel shows that elutJon profiles of plasma from a norrnotriglyceridemic diabetic chdesterol-fed rabbit are similar to those from a nondiabetic chotesterol-fed rabbit. When a diabetic cholesterol-fed rabbit is hypertriglyceridemic, larger lipoproteins appear (third panel). Some of the lipoproteins appear in the void volume. The bottom panel shows elutjon profiles of plasma from the same diabetic rabbit 1 month later. The rabbit is severely hypertriglyceridemic, and the large lipoproteins editing in the void volume prevail.
Since earlier findings in cholesterol-fed rabbits without diabetes 1112 indicate that plasma lipoproteins with diameters larger than 75 nm will have only negligible aortic permeability coefficients, we determined the amounts of cholesterol carried in such large lipoproteins in hypertriglyceridemic diabetic plasma and in normotriglyceridemic nondiabetJc plasma ( Table 1 ). The major part of the cholesterol (68%) in severely hypertriglyceridemic dia- betjc plasma was found in lipoproteins with diameters larger than 75 nm, in contrast to only 12% in normotriglyceridemic plasma.
Furthermore, in the hypertriglyceridemic diabetic rabbits, most of the cholesterol earned in lipoproteins with diameters smaller than 75 nm was earned in VLDL of smaller size, since only about 3% of plasma total cholesterol was found in IDL, LDU and HDL combined ( Table 1) . On the contrary, normotriglyceridemic rabbits carried about 40% of plasma total cholesterol in IDL, LDL, and HDL combined.
Labeled Cholesterol and Protein In Plasma
The different recipient rabbits were injected intravenously with in vivo labeled lipoproteins that had the same size distribution as the recipient rabbits' own lipoproteins. Thus, normotriglyceridemic cholesterol-fed rabbits were injected with labeled normotriglyceridemic plasma preparations (Figure 2, upper panel) , and hypertriglyceridemic diabetic cholesterol-fed rabbits were injected with labeled hypertriglyceridemic diabetic plasma preparations ( Figure  2, lower panel) .
The specific activities in plasma of proteins, of free cholesterol, and of esterified cholesterol from the time of injection until removal of aorta are shown in Figure 3 .
The volumes of distribution for labeled albumin and free and esterified cholesterol were 1.8 to 2.3 times larger In the diabetic rabbits that had been hypertriglyceridemic for 15 to 18 weeks than In the various normotriglyceridemic rabbits ( Table 2 ). Diabetic rabbits, which had been hypertriglyceridemic for only 2 weeks, had volumes of distribution similar to the normotriglyceridemic rabbits.
A decline in protein specific activity was found in all the rabbits (Figure 3) . Likewise, a decline in specific activity for 3 H-esterified cholesterol, 3 H-free cholesterol, and 14 C-free cholesterol was observed in the normotriglyceridemic nondiabetic rabbits (left panel) and in the normotriglyceridemic diabetic rabbits (middle panel). In the hypertriglyceridemic diabetic rabbits, however, these specific activities did not decline during the experimental period (right panel).
The transcapillary escape rates for labeled free and esterified cholesterol were significantly lower in the hypertriglyceridemic diabetic rabbits that had been diabetic for 15 to 18 weeks than in the various normotriglyceridemic rabbits ( Table 2) . Contrarily, the transcapillary escape rate for labeled albumin did not differ between the hypertriglyceridemic and the normotriglyceridemic rabbits. The disappearance from plasma of free and esterified cholesterol expressed as /*mol -kg" 1 • h" 1 was lower in the hypertriglyceridemic diabetic rabbits that had been diabetic for 15 to 18 weeks, than in the normotriglyceridemic rabbits, although the difference was only significant for the free cholesterol values. The corresponding values for albumin did not show this difference.
Influx Measurements
Concentrations of plasma total cholesterol, plasma triglyceride, and blood glucose on the day of the aortic influx measurement are shown in Table 3 . The aortic content of free and esterified cholesterol is also shown. Since aortic influx values and permeability coefficients depend on the cholesterol content of the aorta, 111718 the rabbits were divided into those with high aortic cholesterol content (atherosclerotic) and those with low aortic cholesterol content (nonatherosclerotic). Thereby, aortic influx values and permeability coefficients are comparable between animals within the atherosclerotic group as well as between animals within the nonatherosclerotic group.
In the atherosclerotic group of rabbits, aortic influx of free cholesterol and cholesteryl ester were significantly lower in the hypertriglyceridemic diabetic rabbits compared with the normotriglyceridemic rabbits ( Table 4 ). The values for the atherosclerotic normotriglyceridemic nondiabetic animals were obtained from two earlier studies performed in the same laboratory with the same techniques. 1419 In these studies, plasma proteins and cholesteryl ester in lipoproteins were labeled in vivo in exactly the same manner as in the present study. Table 3 . |p<0.01 when compared with the corresponding compiled group of the various normotriglyceridemic rabbits (Wilcoxon's two-sample rank test).
In the nonatherosclerotic group, two of the hypertriglyceridemic diabetic rabbits had much higher plasma cholesterol concentrations and aortic free and esterifled cholesterol influx rates than the normotriglyceridemic rabbits (see footnotes, Tables 3 and 4 ). The two other hypertriglyceridemic diabetic rabbits in the nonatherosclerotic group with plasma cholesterol concentrations like the normotriglyceridemic rabbits had a tower aortic influx of free and esterified cholesterol than the various normotriglyceridemic rabbits.
Aortic permeabilities of free and esterified cholesterol were significantly lower in all hypertriglyceridemic diabetic rabbits as compared with normotriglyceridemic rabbits, both for atherosclerotic and for nonatherosclerotic rabbits (Table 4 ). To compare arterial permeability of albumin with arterial permeability of lipoproteins in each individual tissue, the ratio of cholesteryi ester permeability to albumin permeability is shown in Figure 4 . This ratio was clearly lower in hypertriglyceridemic, than in normotriglyceridemic, animals. The difference was more pronounced in aortic tissue with atherosclerotic lesions than in aortic tissue without lesions.
The values in Table 4 are not corrected for plasma contamination on the lumlnal aortic surface. When the radioactivity in 10 nl of the final plasma sample 20 was subtracted from the amounts of radioactivity per cm 2 luminal aortic surface before calculation of cholesteryi ester influx and permeability coefficients, the differences between the hypertriglyceridemic diabetic rabbits and the normotriglyceridemic rabbits were even greater than shown in Table 4 .
Discussion
Plasma Lipoproteins and Proteins
By gel filtration and ultracentrifugation, we demonstrated that the lipoproteins in hypertriglyceridemic dia-betic rabbits are much larger than in normotriglyceridemic rabbits. These results are in accordance with earlier reports on such untreated alloxan-diabetic rabbits. 489 Since the same labeled albumin preparations were used to determine the volumes of distribution both in hypertriglyceridemic and normotriglyceridemic rabbits, it is unlikely that the 1.8 to 2.3 times larger volume of distribution in hypertriglyceridemic diabetic cholesterol-fed rabbits as compared to normotriglyceridemic cholesterol-fed rabbits could be due to an artifact. Therefore, the observed large volume of distribution probably represents an expanded plasma volume in the hypertriglyceridemic diabetic cholesterol-fed rabbits.
The difference in transcapillary escape rate of free and esterified cholesterol between the hypertriglyceridemic and the normotriglyceridemic rabbits suggests that the large lipoproteins in the hypertriglyceridemic animals leave the plasma compartment at a much slower rate than do the smaller lipoproteins in the normotriglyceridemic animals. This difference cannot be ascribed only to differences in pool sizes in plasma, since the disappearance from plasma of free and esterified cholesterol (expressed as /unol • kg~1 • h" 1 ) was also lower in the hypertriglyceridemic than in the normotriglyceridemic rabbits. It is noteworthy that albumin had a similar disappearance from plasma in hypertriglyceridemic and normotriglyceridemic animals.
Mechanism of Protection against Atherosclerosis
The lower aortic permeability coefficients of lipoprotein cholesterol In the hypertriglyceridemic diabetic rabbits, as compared to the various normotriglyceridemic rabbits, induced by the alloxan injection per se or by diabetes per se. However, these factors do not appear to explain the low aortic permeability in the hypertrigtyceridemic rabbits, since both alloxan-recovered and normotrigiyceridemic diabetic rabbits had lipoproteJn permeabilities similar to nondjabetjc rabbits. Furthermore, it is not likely that the aortic surface could be generally less permeable in hypertrigtycerkJemlc rabbits than in normotrigiyceridemic rabbits since the aortic permeability to albumin was similar in the two groups of animals. The above observations suggest that the reduced aortic permeability to plasma lipoproteins in the hypertriglyceridemic rabbits can be ascribed more to properties of the lipoproteins than to properties of the aortic wall. The lipoproteins, which carry the major part of plasma cholesterol in hypertrigtyceridemic diabetic rabbits, have a diameter larger than 75 nm. In the nondiabetic hypercholesterolemic rabbit, it has been shown that the aortic permeability coefficients of plasma macromolecules decreases linearly with increasing logarithm of the diameter of the macromolecules. 11 From extrapolation of this relation beyond the size of VLDL (40 to 70 nm), it appears that macromolecules with diameters larger than 75 nm will have only negligible aortic permeability. This has been observed for chytomicrons. 12 It is therefore likely that the large size of the cholesterol-containing lipoproteins (and the relative lack of smaller cholesterol-carrying lipoproteins) in the hypertriglyceridemic diabetic rabbits is the major factor causing the relatively low aortic cholesterol influx. However, it cannot be excluded that changes in other properties of the lipoproteins, such as apoprotein composition, may be of importance. A reduced aortic cholesterol influx means that the subendothelial macrophages and smooth muscle cells are exposed to relatively small amounts of cholesterol. This probably explains the slow development of atherosclerotic plaques in severely hypertrigtyceridemic diabetic rabbits.
The suggestion by Duff and Payne 3 that increased concentrations in plasma lipid phosphorous and possible plasma neutral fat stabilize cholesterol so that it is unable to leave the plasma compartment fits well with our observations. If some large, triglyceride-rich lipoproteins in hypertriglyceridemic diabetic rabbits do enter the arterial endothelium, the relatively slow uptake of these lipoproteins by macrophages 8 may add further to the protection against atherosclerosis.
The slow disappearance of the giant lipoproteins from plasma in the hypertriglyceridemic diabetic rabbits may reflect the same restriction to transendothelial transfer in other tissues as that measured directly for the aortic endothelium. The transfer of macromolecules across the endothelium of capillaries shows a similar relationship with molecular diameter as observed for aortic tissue. 21 -22 
Diabetic Rabbits as Models for Human Diseases
The discrepancy between the facts that humans with diabetes mellitus have more atherosclerosis than nondiabetic humans and that alloxan-diabetes protects against atherogenesis in cholesterol-fed rabbits has been difficult to understand. However, this is not a proper comparison. Untreated alloxan-diabetic rabbits should be compared with untreated insulin-dependent diabetic humans, who, when diagnosed in ketoaddosis, sometimes show hypercholesterolemia of up to 40 mmol/l, severe hypertriglyceridemia of up to 27 mmol/l, and large lipoproteins similar to those observed in the alloxan-diabetic rabbits. 23 -24 ' 25 Hypertriglyceridemia usually never becomes as severe in human diabetics as in diabetic rabbits, since humans are treated with insulin as soon as they are diagnosed.Thus, whether the lipid abnormalities in untreated insulindependent diabetic humans are associated with protection against atherosclerosis as they are in diabetic rabbits is unknown and will probably remain unknown. Insulin treatment reduces elevated plasma triglyceride levels in both insulin-dependent diabetic humans 23 and diabetic rabbits 9 and treatment reverses the anti-atherogenic effect of alloxan-diabetes in cholesterol-fed rabbits. 8 It is not known whether insulin treatment in insulin-dependent diabetic humans is necessary for the development of atherosclerosis.
Humans with lipoprotein lipase deficiency or apolipoprotein-C-ll deficiency exhibit hypercholesterole-428 ARTERIOSCLEROSIS VOL 8, No 4, JULY/AUGUST 1988 mia, severe hypertriglyceridemia, and a lipoprotein pattern similar to that observed in untreated diabetic rabbits or humans. 262728 In spite of the elevated plasma cholesterol level, premature atherosclerosis has so far not been reported in patients with either of these two disorders. 2930 Since the entrance of plasma lipoprotein into the arterial wall of humans and rabbits seems to depend on the sizes of the plasma lipoproteins in a rather similar fashion, 31 these hyperlipidemic humans may be protected from atherosclerosis through a mechanism similar to that proposed for hypertriglyceridemic diabetic rabbits.
In the present study of alloxan-induced diabetes in cholesterol-fed rabbits, we report a number of findings, which suggest that the size of plasma lipoproteins is of major importance for an understanding of the reduced atherogenesis in these rabbits.
